|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013 (Polish Version)
PMR Ltd, March 2011, Pages: 161
Pharmaceutical and healthcare market in Poland 2011 is PMR’s key report providing a comprehensive study of recent trends, developments and forecasts in the pharmaceutical and healthcare sector in Poland. The report analyses both pharmaceutical and healthcare markets and discusses different drug categories including domestic and foreign, refunded and non-refundable, innovative and generic drugs and ATC categories. It provides an analysis of the drug refund system in Poland and examines the impact on the market with the Reimbursement Act to be brought into force alongside other regulatory changes to be introduced by the Ministry of Health.
With the market slowing down, many companies will have to reconsider their business strategies and look for new market opportunities arising with the introduction of dental care insurance and the provision of healthcare services to EU citizens outside their home countries, as part of an EU directive currently under discussion. The report provides development forecasts up to 2013 and growth opportunities in the drug sector as far as the future revenue potential is concerned. In addition to the latest market data, profiles of the top players operating in the pharmaceutical market in Poland and their best selling drugs are included.
Key Highlights:
- Complete market data
- Development forecasts for 2011-2013
- Drug sector segment analysis (domestic and foreign, refunded and non-refundable, innovative and generic drugs and ATC categories)
- Analysis of the drug refund system in Poland
- New market opportunities in the healthcare sector in Poland
- Profiles of the top players in the market
This title is also available in the following language
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013 (English Version)
|
|
|
|
